EY has appointed Pamela Spence as industry leader for its global life sciences practice.
Spence has nearly 20 years of experience working with clients across the life sciences and healthcare sectors, most recently having served as global lead partner for a number of EY’s international life sciences clients.
She first joined EY in 1998 and has since held increasingly senior leadership positions in its transaction advisory services within the health and technology sectors.
In her new role, Spence will continue to serve on the EU global accounts committee, which oversees the strategic direction of all the company’s industry sectors.
She said: “Around the world, companies in the sector are looking to transform and innovate their strategies as they adapt to various health care reforms and the evolving industry landscape.
“New solutions will be required to meet the global challenges of sustainability of healthcare systems, aging populations, chronic disease and increasing cost pressures.
“I look forward to working with our team of dedicated professionals to help our clients respond to these and other challenges.”